Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG
A. Schnell (Bern, Switzerland), D. Lowe (London, United Kingdom), S. Graeter (Bern, Switzerland), M. Davrandi (London, United Kingdom), S. Burns (London, United Kingdom), A. Schaub (Bern, Switzerland), M. Saxenhofer (Bern, Switzerland), M. Hauswald (Marburg, Germany), C. Witte (Marburg, Germany), C. Leboreiro (London, United Kingdom), F. Moreira (London, United Kingdom), I. Irincheeva (Bern, Switzerland), I. Schulze (Bern, Switzerland), C. Vonarburg (Bern, Switzerland), A. Feussner (Marburg, Germany)
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Session: Bronchiectasis heterogeneity: assessing the endotypes
Session type: Oral Presentation
Number: 1315
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Schnell (Bern, Switzerland), D. Lowe (London, United Kingdom), S. Graeter (Bern, Switzerland), M. Davrandi (London, United Kingdom), S. Burns (London, United Kingdom), A. Schaub (Bern, Switzerland), M. Saxenhofer (Bern, Switzerland), M. Hauswald (Marburg, Germany), C. Witte (Marburg, Germany), C. Leboreiro (London, United Kingdom), F. Moreira (London, United Kingdom), I. Irincheeva (Bern, Switzerland), I. Schulze (Bern, Switzerland), C. Vonarburg (Bern, Switzerland), A. Feussner (Marburg, Germany). Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG. 1315
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef) Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001
IgG subclasses in association with respiratory diseases - infection as a consequence or cause of deficiency? Source: Eur Respir J 2001; 18: Suppl. 33, 543s Year: 2001
Treatment with intravenous immunoglobulin (IVG) in children with humoral immune deficiencies and recurrent respiratory tract infections Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001
Recurrent respiratory infections (RRIs): when may be present in children with immunoglobulin deficiency? Source: Eur Respir J 2001; 18: Suppl. 33, 235s Year: 2001
Serum immunoglobulin level is a useful marker for the risk of opportunistic infection in steroid dependent patients with chronic inflammatory airway diseases Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Antibody deficiency in adults with recurrent respiratory tract infections Source: Eur Respir J 2001; 18: Suppl. 33, 106s Year: 2001
Recurrent respiratory tract infections in the preschoolers and IgG3 deficiency Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002
Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014
Increased total, secretory and NTHi-specific IgA in the COPD airway Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
Immunoglobulin treatment with recommended dosages do not prevent deterioration in lung function in primary hypogammaglobulinemia Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006
Pulmonary immunoglobulin E levels and the response to anti-immunoglobulin E antibody therapy in paediatric severe therapy resistant asthma Source: Annual Congress 2012 - Treating childhood asthma Year: 2012
Change of lung function in severe eosinophilic asthma undergoing treatment with anti-interleukin-5 monoclonal antibody Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Economic burden of severe asthma associated with blood eosinophil elevation before introduction of Monoclonal Antibody Therapy Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
Relationship of serum immunoglobulines and IgG subclasses in previously healthy adult patients with community acquired pneumonia Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010
The content of IgE and circulating immune complexes (CIC) in pregnant women with exacerbation of chronic simple bronchitis due to cytomegalovirus infection Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020